Please login to the form below

Capitalising on new drug opportunities in mid-income countries

Opportunities for new drugs in mid-income countries have come under the spotlight, following a survey by Charles River Associates (CRA), which says that more could be done to increase the ‘significant value’ that they are already delivering in five key therapy areas – namely coronary heart disease (CHD), depression, diabetes, HIV/AIDS and rotavirus infection.

Read the Full article here:

12th May 2014